Caisse DE Depot ET Placement DU Quebec Has $199.44 Million Stake in Colgate-Palmolive (NYSE:CL)

Caisse DE Depot ET Placement DU Quebec decreased its stake in Colgate-Palmolive (NYSE:CL) by 28.7% in the 3rd quarter, Holdings Channel.com reports. The firm owned 1,921,168 shares of the company’s stock after selling 773,948 shares during the quarter. Caisse DE Depot ET Placement DU Quebec’s holdings in Colgate-Palmolive were worth $199,436,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Gordian Advisors LLC acquired a new stake in Colgate-Palmolive during the 3rd quarter worth approximately $602,000. Carrera Capital Advisors lifted its holdings in shares of Colgate-Palmolive by 23.1% during the third quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares during the period. Vontobel Holding Ltd. grew its stake in shares of Colgate-Palmolive by 224.6% in the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock worth $82,626,000 after purchasing an additional 550,750 shares during the last quarter. PGGM Investments raised its position in Colgate-Palmolive by 171.8% during the 2nd quarter. PGGM Investments now owns 157,608 shares of the company’s stock worth $15,294,000 after purchasing an additional 99,624 shares during the last quarter. Finally, QRG Capital Management Inc. raised its position in Colgate-Palmolive by 11.2% during the 2nd quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock worth $5,558,000 after purchasing an additional 5,751 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $105.00 to $101.00 in a research report on Monday, October 28th. UBS Group increased their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. StockNews.com upgraded shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. Wells Fargo & Company decreased their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research note on Monday, October 28th. Finally, JPMorgan Chase & Co. raised their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $105.11.

Colgate-Palmolive Stock Performance

Shares of CL opened at $96.60 on Friday. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. The stock has a market capitalization of $78.92 billion, a price-to-earnings ratio of 27.68, a price-to-earnings-growth ratio of 3.45 and a beta of 0.42. Colgate-Palmolive has a 52-week low of $75.50 and a 52-week high of $109.30. The stock’s 50-day simple moving average is $97.38 and its 200 day simple moving average is $98.58.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 2.07%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.